916 related articles for article (PubMed ID: 29023541)
1. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
[TBL] [Abstract][Full Text] [Related]
2. First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection.
Tabynov K; Yespembetov B; Matikhan N; Ryskeldinova S; Zinina N; Kydyrbayev Z; Assanzhanova N; Tabynov K; Renukaradhya GJ; Mukhitdinova G; Sansyzbay A
Vet Microbiol; 2016 Dec; 197():15-20. PubMed ID: 27938677
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Duration of Immunogenicity and Protective Efficacy of Improved Influenza Viral Vector-Based
Mailybayeva A; Ryskeldinova S; Zinina N; Zhou EM; Renukaradhya GJ; Tabynov K
Front Vet Sci; 2020; 7():58. PubMed ID: 32175335
[TBL] [Abstract][Full Text] [Related]
4. An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers.
Tabynov K; Ryskeldinova S; Sansyzbay A
Vaccine; 2015 Jul; 33(31):3619-23. PubMed ID: 26093199
[TBL] [Abstract][Full Text] [Related]
5. Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection.
Tabynov K; Yespembetov B; Ryskeldinova S; Zinina N; Kydyrbayev Z; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
Vaccine; 2016 Jan; 34(4):438-444. PubMed ID: 26709638
[TBL] [Abstract][Full Text] [Related]
6. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.
Tabynov K; Kydyrbayev Z; Ryskeldinova S; Yespembetov B; Zinina N; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Gotskina T; Sansyzbay A
Vaccine; 2014 Apr; 32(18):2034-41. PubMed ID: 24598723
[TBL] [Abstract][Full Text] [Related]
7. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
Tabynov K; Sansyzbay A; Kydyrbayev Z; Yespembetov B; Ryskeldinova S; Zinina N; Assanzhanova N; Sultankulova K; Sandybayev N; Khairullin B; Kuznetsova I; Ferko B; Egorov A
Virol J; 2014 Apr; 11():69. PubMed ID: 24716528
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.
Golshani M; Rafati S; Dashti A; Gholami E; Siadat SD; Oloomi M; Jafari A; Bouzari S
Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468
[TBL] [Abstract][Full Text] [Related]
9. Vaccine Candidate Brucella melitensis 16M
Hensel ME; Garcia-Gonzalez DG; Chaki SP; Hartwig A; Gordy PW; Bowen R; Ficht TA; Arenas-Gamboa AM
mSphere; 2020 May; 5(3):. PubMed ID: 32404509
[TBL] [Abstract][Full Text] [Related]
10. Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7/L12 or Omp16 proteins: evaluation of protection in pregnant heifers.
Tabynov K; Yespembetov B; Sansyzbay A
Vaccine; 2014 Oct; 32(45):5889-92. PubMed ID: 25218295
[TBL] [Abstract][Full Text] [Related]
11. Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing
Bugybayeva D; Ryskeldinova S; Zinina N; Sarmykova M; Assanzhanova N; Kydyrbayev Z; Tabynov K
Biomed Res Int; 2020; 2020():1438928. PubMed ID: 33274194
[TBL] [Abstract][Full Text] [Related]
12. Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model.
Uslu A; Erganis O
Mol Immunol; 2021 May; 133():44-52. PubMed ID: 33631554
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
[TBL] [Abstract][Full Text] [Related]
14. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
15. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous subcutaneous and conjunctival administration of the influenza viral vector based Brucella abortus vaccine to pregnant heifers provides better protection against B. abortus 544 infection than the commercial B. abortus S19 vaccine.
Tabynov K; Orynbayev M; Renukaradhya GJ; Sansyzbay A
Vaccine; 2016 Sep; 34(42):5049-5052. PubMed ID: 27595898
[TBL] [Abstract][Full Text] [Related]
17. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
18. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
[TBL] [Abstract][Full Text] [Related]
19. A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model.
Bugybayeva D; Kydyrbayev Z; Zinina N; Assanzhanova N; Yespembetov B; Kozhamkulov Y; Zakarya K; Ryskeldinova S; Tabynov K
Infect Dis Poverty; 2021 Feb; 10(1):13. PubMed ID: 33593447
[TBL] [Abstract][Full Text] [Related]
20. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
